DD267490A5 - Verfahren zur herstellung von wasserfreiem, kristallinem natriumsalz von 5-chlor-3-(2-thenoyl)-2-odindol-1-carboxamid - Google Patents

Verfahren zur herstellung von wasserfreiem, kristallinem natriumsalz von 5-chlor-3-(2-thenoyl)-2-odindol-1-carboxamid Download PDF

Info

Publication number
DD267490A5
DD267490A5 DD88312599A DD31259988A DD267490A5 DD 267490 A5 DD267490 A5 DD 267490A5 DD 88312599 A DD88312599 A DD 88312599A DD 31259988 A DD31259988 A DD 31259988A DD 267490 A5 DD267490 A5 DD 267490A5
Authority
DD
German Democratic Republic
Prior art keywords
sodium salt
chloro
carboxamide
thenoyl
anhydrous
Prior art date
Application number
DD88312599A
Other languages
German (de)
English (en)
Inventor
Douglas J M Allen
Brian Th O'neill
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD267490A5 publication Critical patent/DD267490A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD88312599A 1987-02-02 1988-02-01 Verfahren zur herstellung von wasserfreiem, kristallinem natriumsalz von 5-chlor-3-(2-thenoyl)-2-odindol-1-carboxamid DD267490A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (1)

Publication Number Publication Date
DD267490A5 true DD267490A5 (de) 1989-05-03

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88312599A DD267490A5 (de) 1987-02-02 1988-02-01 Verfahren zur herstellung von wasserfreiem, kristallinem natriumsalz von 5-chlor-3-(2-thenoyl)-2-odindol-1-carboxamid

Country Status (42)

Country Link
US (1) US5036099A (da)
EP (1) EP0277738B1 (da)
JP (1) JPS63201184A (da)
KR (1) KR900001422B1 (da)
CN (1) CN1022324C (da)
AP (1) AP52A (da)
AR (1) AR243182A1 (da)
AT (1) ATE73800T1 (da)
AU (1) AU587736B2 (da)
BG (1) BG51042A3 (da)
CA (1) CA1335590C (da)
CS (2) CS265250B2 (da)
CY (1) CY1775A (da)
DD (1) DD267490A5 (da)
DE (1) DE3869149D1 (da)
DK (1) DK44888A (da)
EC (1) ECSP941082A (da)
ES (1) ES2032955T3 (da)
FI (1) FI89598C (da)
GR (1) GR3004200T3 (da)
HK (1) HK132695A (da)
IE (1) IE60000B1 (da)
IL (1) IL85277A (da)
IN (1) IN171799B (da)
IS (1) IS1533B (da)
LV (1) LV10252B (da)
MA (1) MA21171A1 (da)
MY (1) MY102737A (da)
NO (1) NO170581C (da)
NZ (1) NZ223373A (da)
OA (1) OA08710A (da)
PH (1) PH26545A (da)
PL (1) PL149550B1 (da)
PT (1) PT86675B (da)
RO (1) RO105052B1 (da)
RU (1) RU2011381C1 (da)
SG (1) SG27994G (da)
SI (1) SI8810183A8 (da)
UA (1) UA25898A1 (da)
WO (1) WO1988005656A1 (da)
YU (1) YU46766B (da)
ZA (1) ZA88679B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US5118703A (en) * 1988-10-18 1992-06-02 Pfizer Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) * 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
EP3703583A4 (en) 2017-11-02 2020-12-30 Accurate Medical Therapeutics Ltd. EMBOLIZATION CATHETER WITH INTEGRATED FILTER

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
DE3582890D1 (de) * 1984-02-07 1991-06-20 Pfizer 2-oxindolzwischenprodukte.
CA1250832A (en) * 1984-03-19 1989-03-07 Pfizer PREPARATION OF 2-OXINDOLE-1-CARBOXAMIDES; INTERMEDIATE PRODUCTS
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
NZ223373A (en) 1989-06-28
LV10252A (lv) 1994-10-20
HK132695A (en) 1995-09-01
FI89598C (fi) 1993-10-25
IL85277A0 (en) 1988-07-31
PL149550B1 (en) 1990-02-28
MY102737A (en) 1992-09-30
PT86675A (pt) 1988-03-01
AP8800081A0 (en) 1987-11-01
DK44888A (da) 1988-08-03
KR900001422B1 (ko) 1990-03-09
WO1988005656A1 (en) 1988-08-11
NO170581C (no) 1992-11-04
US5036099A (en) 1991-07-30
CY1775A (en) 1996-04-05
FI893647A0 (fi) 1989-08-01
KR880009961A (ko) 1988-10-06
CS64888A2 (en) 1988-08-16
BG51042A3 (en) 1993-01-15
NO170581B (no) 1992-07-27
JPH0576945B2 (da) 1993-10-25
CN1022324C (zh) 1993-10-06
DK44888D0 (da) 1988-01-29
PH26545A (en) 1992-08-19
DE3869149D1 (de) 1992-04-23
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
EP0277738A1 (en) 1988-08-10
AR243182A1 (es) 1993-07-30
AU587736B2 (en) 1989-08-24
CS354191A3 (en) 1992-04-15
YU46766B (sh) 1994-05-10
SG27994G (en) 1994-10-14
CA1335590C (en) 1995-05-16
ATE73800T1 (de) 1992-04-15
ES2032955T3 (es) 1996-07-16
UA25898A1 (uk) 1999-02-26
ZA88679B (en) 1989-09-27
FI89598B (fi) 1993-07-15
IE60000B1 (en) 1994-05-18
GR3004200T3 (da) 1993-03-31
RO105052B1 (en) 1994-12-01
AU1116088A (en) 1988-08-04
SI8810183A8 (sl) 1996-08-31
IS1533B (is) 1994-01-28
AP52A (en) 1989-09-16
ECSP941082A (es) 1994-12-15
OA08710A (fr) 1989-03-31
CN88100555A (zh) 1988-08-17
CS265250B2 (en) 1989-10-13
MA21171A1 (fr) 1988-10-01
RU2011381C1 (ru) 1994-04-30
EP0277738B1 (en) 1992-03-18
NO884329L (no) 1988-09-29
NO884329D0 (no) 1988-09-29
PT86675B (pt) 1992-07-31
IL85277A (en) 1994-02-27
YU18388A (en) 1989-10-31
PL270415A1 (en) 1988-12-08
IE880269L (en) 1988-08-02
IS3309A7 (is) 1988-08-03
IN171799B (da) 1993-01-09

Similar Documents

Publication Publication Date Title
DD267490A5 (de) Verfahren zur herstellung von wasserfreiem, kristallinem natriumsalz von 5-chlor-3-(2-thenoyl)-2-odindol-1-carboxamid
DE3143219C2 (da)
DE69720774T2 (de) S-omeprazol in festform
DE3005164C2 (de) 1,1-Dioxopenicillanoyloxymethyl-6-(D-α-amino-α-phenylacetamido)-penicillanat, Verfahren zu seiner Herstellung und es enthaltendes Arzneimittel
DE19546249A1 (de) Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2351412C2 (de) 2,2-Disubstituierte 1-Oxo-5-indanyloxy-carbonsäuren, Verfahren zu deren Herstellung und Spaltung racemischer Gemische, sowie diese enthaltende Arzneimittel
CH654004A5 (de) Kristallmodifikationen des monohydrats und der wasserfreien form von (+)-catechin, verfahren zu deren herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.
DE60131416T2 (de) Chirale fluochinolon-argininsalzformen
WO2002036115A1 (de) Sulfonamiden zur behandlung von erkrankungen des zentralen nervensystems
DE3139554C2 (da)
DE2655130C3 (de) Eine praktisch lösungsmittelfreie Kristallform des Cefacetril-Natriumsalzes
AT345781B (de) Verfahren zur herstellung von neuen 3- aminomethyl-2-phenylbicyclo (2,2,2) octanen und -octenen sowie deren saeureadditionssalzen
DE3113150A1 (de) Isophthalsaeurepicolylamidmonohydrat, verfahren zu seiner herstellung und dessen pharmazeutische verwendung
EP0253293B1 (de) Neue Guanidiniumasparaginate
EP0308665B1 (de) Salze der 5-Aminosalicylsäure und sie enthaltende Arzneimittelzubereitungen
DE2244265A1 (de) Neue imidazolderivate, ihre herstellung und die medizinischen zusammensetzungen, die sie enthalten
CH675419A5 (da)
DE2055853C3 (de) Procain-Phenylbutazon, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen
DE2043817C3 (de) 1,4-Dihydro-3-carboxy-cyclopentano-(h)-chinolon-(4)-derivate, Verfahren zu deren Herstellung sowie deren Verwendung zur Bekämpfung antibakterieller Erkrankungen
AT221501B (de) Verfahren zur Herstellung der neuen 4-Chlor-3-sulfamyl-benzoesäure und deren Alkalisalze
DE2309100C2 (de) N-Acylierte Aminophenolätherderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Formulierung zur Behandlung von Leberegelinfektionen bei Säugern
DE2839311C2 (de) Pharmazeutisches Präparat gegen Geschwüre
DE2404308C3 (de) Thieno bzw. Furo [3,2-c] pyridiniumderivate sowie deren 43,6,7-Tetrahydroderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2019145C3 (de) Kristallines Monohydrat und Verfahren zu seiner Herstellung
AT335605B (de) Verfahren zur herstellung neuer acylderivate des antibiotikums ws-4545

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee